This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
In ongoing trials of Eli Lilly’s next-generation obesity drug, several trial participants are running into an issue they never expected: They are losing too much weight. One participant lost 22% of her weight in nine months — substantially faster than the rate seen with approved GLP-1 drugs like Wegovy or Zepbound. Her weight dropped so much that researchers reduced her dose of the treatment, called retatrutide.
The International Generic and Biosimilar Medicines Association (IGBA) has released a report titled “Gaming the System An Overview of Originator Companies Evergreening Strategies Used to Hinder Access to Generic and Biosimilar Products.” The report outlines market practices that delay the entry of generic and biosimilar medicines, affecting affordability and competition in global healthcare.
The pharmaceutical industry is in a period of rapid transformation. Driven by innovation and evolving patient needs, companies face challenges balancing competitiveness, regulatory hurdles, R&D improvements, and diversity initiatives. Three key trends define this era: 1. Diversity in Clinical Trials: A Core Priority Diversity in trials is shifting from compliance to a core design element.
Panelists discuss how pharmacists play a crucial role in optimizing health outcomes for women with complex health needs through comprehensive medication management, personalized consultations, and interdisciplinary collaboration. They provide targeted medication therapy, monitor drug interactions, offer medication counseling, manage chronic conditions, support reproductive health, and help patients navigate complex treatment regimens with expertise and compassionate care.
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
January 30, 2025: “The U.S. Food and Drug Administration approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid analgesic, to treat moderate to severe acute pain in adults. Journavx reduces pain by targeting a pain-signaling pathway involving sodium channels in the peripheral nervous system, before pain signals reach the brain.
As healthcare shifts toward value-based care, medication reconciliation has become a critical focus for reducing costs and improving patient outcomes. Discrepancies in medication regimens, particularly during care transitions like hospital discharge, are a leading cause of adverse drug events (ADEs). These preventable issues result in significant financial burdens on healthcare systems while compromising patient safety and care quality.
A federal judge will soon decide whether a class action lawsuit against UnitedHealth Group and its algorithm-based care denials can move forward, which would potentially open the door for attorneys to sift through the company’s internal communications. The lawsuit, in U.S. District Court in Minnesota, alleges that UnitedHealth and its subsidiary NaviHealth relied on flawed algorithms to cut off essential rehabilitative care to sick and injured Medicare Advantage beneficiaries.
A federal judge will soon decide whether a class action lawsuit against UnitedHealth Group and its algorithm-based care denials can move forward, which would potentially open the door for attorneys to sift through the company’s internal communications. The lawsuit, in U.S. District Court in Minnesota, alleges that UnitedHealth and its subsidiary NaviHealth relied on flawed algorithms to cut off essential rehabilitative care to sick and injured Medicare Advantage beneficiaries.
The nutraceutical market is expanding rapidly, valued at $6.11 billion in 2024 and projected to reach $11.55 billion by 2030, according to a GlobeNewsWire report. However, pharma companies eager to tap into this growth, face a complex road ahead. Regulatory ambiguity, for instance, serves as a double-edged sword. On the one hand, relatively less regulatory control eases market entry; on the other, they expose pharma players to intense competition from both established FMCG brands and agile start
In a rapidly transforming pharmaceutical landscape, securing market access remains paramount. Looking ahead in 2025, several pivotal trends are set to redefine strategies for manufacturers and industry stakeholders. 1. Digital Health: Redefining Patient Support and Engagement Digital health technologies, including AI, are fundamentally changing patient interactions and support services.
Pharmacists are experiencing 'moral injury' with more than half of pharmacy professionals reporting that medicines shortages have impacted their mental health and wellbeing, according to the Royal Pharmaceutical Society (RPS). Its most recent workforce wellbeing survey also found that inadequate staffing was affecting wellbeing for 70% of pharmacy professionals, with just 35% of pharmacists able […] The post Medicines shortages causing 'moral injury', suggests RPS survey appeared
Interim results from a Phase III trial have demonstrated promising efficiency of Novo Nordisks Factor VIIIa (FVIIIa) mimetic bispecific antibody in children living with haemophilia A with and without inhibitors.The FRONTIER3 trial evaluating Mim8 enrolled a total of 70 children aged between one and 11 years old. Key outcomes from the FRONTIER3 trial Part one of the study involved participants receiving once-weekly doses of the treatment.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
By Steven J. Gonzalez & Allyson B. Mullen As the device industry is well aware, one of the greyest areas in device regulation (of which there are many) is determining when changes to a 510(k)-cleared device trigger the need for a new clearance. FDA requires a new 510(k) clearance when a modification to an existing 510(k)-cleared device (or other existing device subject to 510(k) requirements) could significantly affect the safety or effectiveness of the device.
In an era punctuated by school shootings and ongoing debates about gun control and gun rights, America’s public schools continue to be riddled with safety concerns. According to the New York Times, “Since 2017, tens of millions have been spent by the federal government on mass shooter training, and states have spent even more.” The result of our culture’s focus on crisis management over prevention is more security staff in high schools than there are
The healthcare industry reported 107 mergers and acquisitions (M&A) deals worth $29.2 billion in January 2025, according to data from GlobalData. This is higher than the last 12-month (January 2024 to December 2024) average of 99 deals worth $14 billion. Johnson & Johnson announced the acquisition of Intra-Cellular Therapies, a biopharmaceutical company, for a total equity value of approximately $14.6 billion.
Introduction In an era dominated by digital marketing, traditional advertising remains a vital tool for pharma companies to connect with healthcare professionals (HCPs) and patients alike. While online platforms grow, traditional channels such as print ads, TV commercials, and conferences continue to play a crucial role in boosting brand visibility and driving meaningful engagement.
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
Patients in England have lost around seven million hours of pharmacy access in the last two years, analysis from the National Pharmacy Association (NPA) has suggested. And around one in eight have seen their local pharmacy close for good, the NPA said. Inadequate funding could force pharmacies to reduce access by a further one million […] The post Seven million hours of pharmacy access lost in two years appeared first on The Pharmacist.
In this episode, I’ll discuss the impact of compounded oral vancomycin liquid on hospital readmission for C diff infection. Episode 1001: Saving Money on Oral Vancomycin Is Great For Inpatients But Can Cause Problems On Discharge Subscribe on iTunes , Android , or Stitcher The drug acquisition cost for oral vancomycin capsules is several orders of magnitude larger than for liquid vancomycin prepared from the IV formulation and given via the oral route.
A study has demonstrated a new approach to prepare tablets for intestinal drug delivery by combining two 3D printing techniques. Using both selective laser sintering (SLS) and fused deposition modelling (FDM), the technique has potential to achieve delayed and prolonged drug release, according to the findings. Key findings from the 3D printing drug delivery study [a] laser speed of 90 mm s1 was suitable for producing [3D printed tablet] cores with relatively short disintegration time and suffici
Change has come to the Department of Health and Human Services. With the confirmation of Robert F. Kennedy Jr. as secretary, major shifts in organizational structure, staffing , and policy priorities across the department are already underway. But not all HHS agencies are created equal, and some deserve to be modified with a scalpel rather than a sledgehammer.
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Chairman of Zydus, Pankaj Patel, emphasised the importance of people in organisational success during the launch of the School of Ultimate Leadership (SOUL) in Gujarat on Friday. Speaking at the event, formally inaugurated by Prime Minister Narendra Modi, Patel stated, People are the core to anything you do. The only mantra to succeed in any business is to take care of your people; other things will follow.
Introduction Pharmacy Enforcement plays an important role in ensuring pharmaceuticals, traditional and cosmetics available in the market are genuine in terms of registration and notification. It also oversees the supply chain, marketing, advertising (including medical services) and usage of these produts, ensuring compliance with existing legislation.
Gisela Abbam has been re-appointed as chair of the General Pharmaceutical Council (GPhC) for another term, until 2029. This was announced today at a GPhC committee meeting, following a re-appointment process overseen by two council members at the end of their terms: pharmacist Elizabeth Mailey and layperson Jayne Salt. As part of the process, the […] The post Gisela Abbam reappointed GPhC Chair until 2029 appeared first on The Pharmacist.
As specialty medications revolutionize treatment for chronic and complex conditions, their rising costs and intricate management requirements place a significant strain on patients, payers and providers. Without structured oversight, adherence issues, adverse drug interactions and financial barriers can lead to poor outcomes and unnecessary healthcare costs.
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
Introduction: In 2025, programmatic advertising will continue to redefine how pharmaceutical brands reach healthcare providers (HCPs) and patients. For pharma marketing teams, staying ahead of programmatic advertising trends is not just importantits essential for success. But what trends will shape the future, and how can your team leverage them to drive results?
XRHealth is on a shopping spree, buying three companies in as many years, as it aims to build a leading platform for therapeutic virtual reality. The latest: It’s acquiring RealizedCare, a company that couples immersive experiences with coaches for chronic pain management. XRHealth and RealizedCare own assets for a range of virtual reality headset-based experiences designed to help treat mental health, chronic pain, and other conditions.
India Ratings and Research (Ind-Ra) has maintained a Neutral Outlook for the pharmaceuticals sector in FY26. The agency projects overall revenue growth of 9 per cent-10 per cent year-on-year, driven by growth in the domestic chronic segment, US generics, and the contract development and manufacturing organisation (CDMO) business. EBITDA margins are expected to remain at historically elevated levels over FY25-FY26, supported by growth in high-value products, moderation in pricing pressures, cost
The Dark Side of Innovation: How Companies Use Drug Patents to Block Competitors As we celebrate the breakthroughs in medical research and the development of life-saving treatments, it's essential to acknowledge the complex landscape of pharmaceutical innovation. Behind the scenes, companies are employing clever tactics to protect their intellectual property and block competitors from entering the market.
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
Online treatment service providers have been encouraged 'to review their commercial relationships with third parties' to ensure they abide by medicines advertising regulations, particularly regarding weight-loss medications. This comes as one company, Habitual Healthcare, has changed how it collaborates with online influencers, on the advice of the Medicines and Healthcare Regulatory Agency (MHRA).
When the pharma firm cancelled plans for a major expansion of its Merseyside plant last month, there was no shortage of questions or blame over responsibility At a tense meeting with senior civil servants on the afternoon of 29 January, the chair of AstraZeneca, Shaun Grady, pulled the plug on a planned 450m expansion of its childhood flu vaccine factory in Merseyside bringing a year and a half of negotiations to an abrupt halt.
Introduction In todays fast-paced world, pharma digital marketing is more than just a strategyit’s a necessity. With increasing competition, strict regulations, and changing consumer behavior, pharmaceutical brands must embrace digital transformation to stay relevant. But how can pharma marketers break through the noise, engage their audience, and see real ROI?
Where is DeepMind’s AI protein design spinout? The Alphabet-owned AI company took the biology world by storm in 2020 with AlphaFold2 , the protein structure prediction AI platform that “solved” a decades-old biology problem. In 2021, the company spun out Isomorphic Labs, an AI drug discovery company. But Isomorphic’s initial focus is on small-molecule drug discovery, with protein-based drugs remaining a distant twinkle in the company’s eye.
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content